994 results match your criteria: "National Addiction Centre.[Affiliation]"
Lancet Psychiatry
August 2023
School of Heath and Social Care, Edinburgh Napier University, Edinburgh, UK.
Approximately 30-50% of people with serious mental illness have co-existing drug or alcohol problems (COSMHAD), associated with adverse health and social care outcomes. UK guidelines advocate both co-occurring needs being met within mental health services, but uncertainty remains about how to operationalise this to improve outcomes. Various unevaluated service configurations exist in the UK.
View Article and Find Full Text PDFBMJ Open
April 2023
National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Objectives: Electronic vaping devices are being used to consume nicotine and non-nicotine psychoactive drugs. We aimed to determine the pattern and prevalence of using vaping devices for nicotine and/or non-nicotine drug administration in the United Kingdom and how these differ by drug type and individual sociodemographic characteristics. We explored reasons for vaping onset and continuation.
View Article and Find Full Text PDFAddict Behav
September 2023
National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address:
Psychol Med
November 2023
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
Background: While cannabis use is a well-established risk factor for psychosis, little is known about any association between reasons for first using cannabis (RFUC) and later patterns of use and risk of psychosis.
Methods: We used data from 11 sites of the multicentre European Gene-Environment Interaction (EU-GEI) case-control study. 558 first-episode psychosis patients (FEPp) and 567 population controls who had used cannabis and reported their RFUC.
J Stud Alcohol Drugs
July 2023
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford University, Stanford, California.
Within the addiction field, some advocates support a suite of de-regulatory policies that aim to reduce harm by providing people who use drugs with a "safe supply" of pharmaceutical-grade medications. Such initiatives have commenced without the evidence standards normally used to label medication provision as "safe." This perspective suggests that continued debate and research in this area acknowledge the potential toxicity of any provided safe supply medications and highlights that these initiatives could result in an unhelpful reduction in interactions between people who use drugs and health care professionals.
View Article and Find Full Text PDFInt J Drug Policy
April 2023
National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, St Lucia, QLD, 4072, Australia; National Addiction Centre, Institute of Psychiatry, Kings College London, UK.
Int J Drug Policy
April 2023
National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, St Lucia, QLD, 4072, Australia; National Addiction Centre, Institute of Psychiatry, Kings College London, UK.
Subst Abuse
April 2023
Centre for Addiction and Mental Health, Toronto, ON, Canada.
Introduction: This study examines normative misperceptions in a sample of participants recruited for a brief intervention trial targeting risky cannabis use.
Methods: Participants who were concerned about their own risky cannabis use were recruited to help develop and evaluate intervention materials. At baseline, participants reported on their own cannabis use and provided estimates of how often others their gender and age used cannabis in the past 3 months.
BJPsych Open
April 2023
Division of Psychiatry, Imperial College London, London, UK; and Prescribing Observatory for Mental Health, Centre for Quality Improvement, Royal College of Psychiatrists, London, UK.
Background: Medically assisted alcohol withdrawal (MAAW) is increasingly undertaken on acute adult psychiatric wards.
Aims: Comparison of the quality of MAAW between acute adult wards and specialist addictions units in mental health services.
Method: Clinical audit conducted by the Prescribing Observatory for Mental Health (POMH).
Addiction
August 2023
The National Centre for Youth Substance Use Research, The University of Queensland, Brisbane, QLD, Australia.
Background And Aims: Heated tobacco products (HTPs) are electronic devices that heat process tobacco to release an aerosol containing nicotine and other chemicals. Limited data exist on world-wide HTP use prevalence. This meta-analytic review estimated the prevalence of HTP use by country, World Health Organization (WHO) region, year, sex/gender and age.
View Article and Find Full Text PDFInt J Drug Policy
March 2023
National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, St Lucia, QLD, 4072, Australia; National Addiction Centre, Institute of Psychiatry, Kings College London, UK.
Int J Drug Policy
May 2023
School of Public Health Sciences, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, Canada, N2L 3G1. Electronic address:
Background: Minimum legal age (MLA) restrictions are a core policy to reduce youth use of tobacco, e-cigarettes, and other substances. We examined trends in perceived ease of access to tobacco and other substances across three countries with differing MLA policies, including the United States (US), which increased the federal MLA for tobacco products from 18 to 21 in 2019.
Methods: Repeat cross-sectional data were analyzed from seven waves of the International Tobacco Control (ITC) Youth Tobacco and Vaping Survey conducted between 2017 and 2021.
Drug Alcohol Rev
May 2023
National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
JMIR Hum Factors
March 2023
Department of Vulnerabilities and Social Medicine, Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.
Background: Despite considerable efforts devoted to the development of prevention interventions aiming at reducing unhealthy alcohol use in tertiary students, their delivery remains often challenging. Interventions including information technology are promising given their potential to reach large parts of the population.
Objective: This study aims to develop a secondary prevention smartphone app with an iterative qualitative design involving the target population.
Sci Rep
March 2023
Department of Addictology and Psychiatry Nantes, Inserm U1246, CHU Nantes, Université de Nantes, Université de Tours, Nantes, France.
Addiction
June 2023
Harvard Medical School, Director, Tobacco Research and Treatment Center, Massachusetts General Hospital, Massachusetts, Boston, USA.
This paper critically analyses a statement by Australia's National Health and Medical Research Council (NHMRC) on e-cigarettes in May 2022 that will be used to guide national policy. We reviewed the evidence and the conclusions drawn in the NHMRC Statement. In our view, the Statement is not a balanced reflection of the benefits and risks of vaping because it exaggerates the risks of vaping and fails to compare them to the far greater risks of smoking; it uncritically accepts evidence of harms from e-cigarettes while adopting a highly sceptical attitude towards evidence of their benefits; it incorrectly claims that the association between adolescent vaping and subsequent smoking is causal; and it understates the evidence of the benefits of e-cigarettes in assisting smokers to quit.
View Article and Find Full Text PDFAddiction
July 2023
National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8BB, UK.
Background And Aims: Long-acting injectable buprenorphine (LAIB) is a new treatment for opioid use disorder that is generating positive outcomes. Negative effects are typically mild and transient, but can occasionally be serious, resulting in treatment discontinuation/non-adherence. This paper aims to analyse patients' accounts of how they felt during the first 72 h after initiating LAIB.
View Article and Find Full Text PDFDrug Alcohol Depend
March 2023
King's College London, Institute of Psychiatry, Psychology and Neuroscience, National, National Addiction Centre, 4 Windsor Walk, Denmark Hill Campus, London SE5 8BB, UK. Electronic address:
Background: The prevalence of drug use in Muslim communities is difficult to estimate due to religious, social, and cultural prohibition toward drug use. With Islam affecting all aspects of life in the Muslim world, people who use drugs do it clandestinely to avoid stigma and exclusion from the community, leading to a low number of them seeking treatment for their drug use. This review explored the barriers and facilitators to accessing inpatient and community substance use treatment and harm reduction services for people who use drugs in Muslim communities.
View Article and Find Full Text PDFJ Subst Use Addict Treat
April 2023
Department of Psychology, Health Psychology Section, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Department of Inflammation Biology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Background: Mothers compose a significant proportion of women in substance use treatment services. These women have needs that, if not addressed, can negatively impact their capacity to parent. This study explores the feasibility of using free-text notes from electronic health records (EHRs) to identify factors that impair mothers' ability to care for their children.
View Article and Find Full Text PDFJ Stud Alcohol Drugs
January 2023
Addictions Department, National Addiction Centre, Institute of Psychiatry, King's College London, London, United Kingdom.
Objective: This article presents the benzodiazepine concentrations in urine samples from participants undergoing alcohol withdrawal in a Phase 4 "Proof of Concept" double-blind, randomized, controlled clinical trial. Chlordiazepoxide was prescribed to all participants "as needed" during the first 2 weeks only of alcohol withdrawal, to prevent serious consequences such as seizures. The trial examined effects of either mifepristone or placebo on the primary trial outcomes, which included cognitive function tests at 3 weeks and 4 weeks after the cessation of drinking.
View Article and Find Full Text PDFNat Med
March 2023
Department of Medicine, Harvard Medical School, Boston, MA, USA.
BMC Public Health
February 2023
Centre for Psychological Research, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.
Background: Intimate partner violence and abuse (IPVA) includes controlling behaviours, psychological, physical, sexual and financial abuse. Globally, surveys and emergency services have recorded an increase in IPVA since restrictions were imposed to limit COVID-19 transmission. Most studies have only included heterosexual women.
View Article and Find Full Text PDFAddiction
July 2023
Cardiovascular Epidemiology of Aging, Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.
Background And Aims: The addictive potential of electronic cigarettes (e-cigarettes) remains to be fully understood. We identified patterns and correlates of perceived addiction to e-cigarettes and perceived addictiveness of e-cigarettes relative to tobacco cigarettes (relative addictiveness) in dual users as well as exclusive e-cigarette users.
Design, Setting And Participants: Observational study using cross-sectional survey data from England (2016) from the International Tobacco Control Project (ITC) Four Country Smoking and Vaping (4CV) survey.
Eur Addict Res
June 2023
School of Psychology, University of Lincoln, Lincoln, UK.
Introduction: Data from several areas of public health (e.g., harmful alcohol and tobacco) are consistent with the assertion that children's exposure to advertising strategies increases intention to consume such products.
View Article and Find Full Text PDFBMC Psychiatry
February 2023
Division of Health Research, Lancaster University, Lancaster, UK.
Background: There is strong evidence for the co-occurrence of mental health conditions and alcohol problems, yet physical health outcomes among this group are not well characterised. This study aimed to identify clusters of physical health conditions and their associations with mental health and problematic alcohol use in England's general population.
Methods: Cross-sectional analysis of the 2014 Adult Psychiatric Morbidity Survey (N = 7546) was conducted.